Blogs

Latest Blogs

S-Pindolol: The Fight Against Cancer Cachexia

Cancer cachexia is a silent thief. It robs patients of strength, stripping away muscle and fat, leaving them frail and exhausted.…

Allogeneic CAR T cell therapies: A major step forward

In a groundbreaking clinical trial, three individuals suffering from severe autoimmune diseases have entered remission following a novel CAR T…

A controlled detonation: Targeted antibody drug conjugates (ADCs) for oncology

Are antibody-drug conjugates (ADCs), principally comprised of an antibody, a cytotoxic payload and a linker, the next therapeutic modality of…

The mpox outbreak: Variants, transmission and the boost for vaccine manufacturers

Following Covid-19, the world is collectively on high alert for anything that could indicate another pandemic. What do we know…

The STING in the tail: How our own defense mechanisms to infection may be working against us

In this latest blog, we explore this pathway, its burgeoning links to multiple diseases and how biomarker profiling can assist…

Falling drug approval rates: What should we be doing differently?

Over the years, this failure rate of drug approvals has not seen significant improvement, which begs the question - why?…

Patient Derived Organoids: Shaping the Fight Against Paediatric Brain Cancer

We highlight some of the exciting translational tools that have been developed to understand brain cancer and how these are…

Quick Links

Talk to our Biomarker Experts